Ocular tissue LC-MS/MS bioanalysis laboratory services supporting ocular drugs preclinical or clinical development
Intertek's ocular tissue LC-MS/MS bioanalysis experience extends over a decade in regard to development and highly optimised validation for a wide variety of compounds in multiple ocular matrices of different species which adhere closely to regulated bioanalysis guidance.
A diverse platform of homogenization and extraction techniques is available for processing ocular tissues and fluids to ensure optimal recovery of analytes. Technologies such as multi-tube bead homogenization and high energy ultrasonication are often employed individually, or in conjunction with more traditional processing techniques.
Non-GLP studies are also routinely conducted to support discovery, lead optimization and proof of concept programs of ocular drugs.
Methods have been validated in the following ocular matrices:
Need help or have a question?